AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Ciprofloxacin in South Africa

10 products registered with SAHPRA — 6 active

Brand / ProductReg. No.HolderStatusExpires
ADCO CIPROFLOXACIN 2 mg/ml INFUSION43/20.1.1/1025Adcock Ingram Limitedsuspended31 Mar 2026
CIPLOXX IV 10037/20.1.1/0294Cipla Medpro (Pty) Ltdsuspended18 Jul 2025
CIPLOXX-IV 20037/20.1.1/0295Cipla Medpro (Pty) Ltdsuspended18 Jul 2025
CIPROBAY XR 50037/20.1.1/0250Bayer (Pty) Ltd û Isandosuspended25 Mar 2022
CIPROGEN IVA40/20.1.1/0618Viatris South Africa (Pty) Ltdactive1 Jan 1900
MYLAN CIPROFLOXACIN 200 mg/100 ml43/20.1.1/0955Viatris Healthcare (Pty) Ltdactive1 Jan 1900
MERCK-CIPROFLOXCIN IV41/20.1.1/0390Viatris South Africa (Pty) Ltdactive1 Jan 1900
CIPROBAY SUSPENSION 5 %31/20.1.1/0111Bayer (Pty) Ltd û Isandoactive1 Jan 1900
MYLAN CIPROFLOXACIN 400 mg/200 ml43/20.1.1/0956Viatris Healthcare (Pty) Ltdactive1 Jan 1900
CIPROBAY IVY/20.1.1/311Bayer (Pty) Ltd û Isandoactive1 Jan 1900

Ciprofloxacin — SAHPRA Registration Details

SAHPRA (South Africa) has 10 registered products containing Ciprofloxacin, of which 6 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Ciprofloxacin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.